BioCryst Pharmaceuticals Inc (BCRX)
7.51
+0.21
(+2.88%)
USD |
NASDAQ |
Nov 21, 15:53
BioCryst Pharmaceuticals Market Cap: 1.556B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.512B |
| November 19, 2024 | 1.493B |
| November 18, 2024 | 1.462B |
| November 15, 2024 | 1.456B |
| November 14, 2024 | 1.543B |
| November 13, 2024 | 1.582B |
| November 12, 2024 | 1.620B |
| November 11, 2024 | 1.696B |
| November 08, 2024 | 1.611B |
| November 07, 2024 | 1.589B |
| November 06, 2024 | 1.601B |
| November 05, 2024 | 1.461B |
| November 04, 2024 | 1.522B |
| November 01, 2024 | 1.746B |
| October 31, 2024 | 1.659B |
| October 30, 2024 | 1.734B |
| October 29, 2024 | 1.682B |
| October 28, 2024 | 1.688B |
| October 25, 2024 | 1.647B |
| October 24, 2024 | 1.694B |
| October 23, 2024 | 1.669B |
| October 22, 2024 | 1.647B |
| October 21, 2024 | 1.558B |
| October 18, 2024 | 1.578B |
| October 17, 2024 | 1.551B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.568B |
| October 15, 2024 | 1.549B |
| October 14, 2024 | 1.545B |
| October 11, 2024 | 1.539B |
| October 10, 2024 | 1.475B |
| October 09, 2024 | 1.502B |
| October 08, 2024 | 1.491B |
| October 07, 2024 | 1.541B |
| October 04, 2024 | 1.570B |
| October 03, 2024 | 1.537B |
| October 02, 2024 | 1.529B |
| October 01, 2024 | 1.529B |
| September 30, 2024 | 1.574B |
| September 27, 2024 | 1.576B |
| September 26, 2024 | 1.568B |
| September 25, 2024 | 1.562B |
| September 24, 2024 | 1.579B |
| September 23, 2024 | 1.612B |
| September 20, 2024 | 1.678B |
| September 19, 2024 | 1.686B |
| September 18, 2024 | 1.647B |
| September 17, 2024 | 1.639B |
| September 16, 2024 | 1.636B |
| September 13, 2024 | 1.639B |
| September 12, 2024 | 1.603B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
246.71M
Minimum
Mar 18 2020
3.649B
Maximum
Feb 16 2022
1.630B
Average
1.562B
Median
May 31 2023
Market Cap Benchmarks
| AIM ImmunoTech Inc | 13.49M |
| Perspective Therapeutics Inc | 204.11M |
| Protalix BioTherapeutics Inc | 122.23M |
| Electromed Inc | 236.82M |
| Armata Pharmaceuticals Inc | 75.98M |
Market Cap Related Metrics
| PS Ratio | 3.736 |
| Price | 7.51 |
| Earnings Yield | -8.12% |